EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Bismuth-based nanosystems for precise tumor theranostics: Recent progress, challenges and perspectives

Haohao Zhang, Mengge Guo, Zhen Kong, Yujie Ma, Laixin Hong, Mingyuan Pang, Zimai Wang, Min Yang, Juan An, Yen Leng Pak, Jibin Song

Theranostics · 2026

DOI: 10.7150/thno.140822 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Theranostics, 2026. Verfasst von Haohao Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan 250200, China. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Bismuth, Neoplasms, Nanostructures. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precision tumor diagnosis and treatment are constrained by inaccurate early diagnosis, therapeutic resistance, immunosuppressive tumor microenvironments, and toxic side effects of drugs, resulting in unsatisfactory efficacy of monotherapies. Multifunctional nanoplatforms capable of integrating multimodal imaging, synergistic therapy and immune regulation constitute a core research focus in precision oncology. Bi-based nanomaterials exhibit high X-ray attenuation, tunable band structures, excellent photoacoustic/catalytic performance and controllable degradability, rendering them suitable for imaging-guided precision tumor theranostics. This article systematically reviews four categories of Bi-based nanomaterials: elemental/single-phase, heterostructures, core-shell structures, and Bi-based/containing MOFs. We summarize strategies for structural modification and structure-activity relationship optimization, elaborate their advantages in multimodal imaging, as well as synergistic anti-tumor mechanisms combining phototherapy, radiotherapy, sonodynamic therapy and immunotherapy, including activation of regulated cell death, tumor microenvironment remodeling, and tumor growth inhibition and anti-metastasis effects. Furthermore, the bottlenecks hindering their clinical translation are outlined, and prospects for the development of precision nanotheranostics are proposed. This work provides theoretical references for the clinical translation of Bi-based nanomaterials for tumor theranostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Theranostic NanomedicineBismuthNeoplasmsNanostructuresHumansAnimalsTumor MicroenvironmentMultimodal Imaging

Stichwörter der Autor:innen

Bi-based nanomaterialsimmune microenvironment regulationmultimodal imagingnanotheranosticssynergistic tumor therapy

Substanzen

Bismuth

Autor:innen und Institutionen

  • College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan 250200, China.
  • College of Chemistry, Beijing University of Chemical Technology, Beijing 10010, China.

Zitieren

APA

Zhang, H., Guo, M., Kong, Z., Ma, Y., Hong, L., Pang, M., Wang, Z., Yang, M., An, J., Pak, Y. L., & Song, J. (2026). Bismuth-based nanosystems for precise tumor theranostics: Recent progress, challenges and perspectives. Theranostics. https://doi.org/10.7150/thno.140822

Vancouver

Zhang H, Guo M, Kong Z, Ma Y, Hong L, Pang M, et al. Bismuth-based nanosystems for precise tumor theranostics: Recent progress, challenges and perspectives. Theranostics. 2026. doi:10.7150/thno.140822

BibTeX
@article{Zhang2026,
  author = {Zhang, Haohao and Guo, Mengge and Kong, Zhen and Ma, Yujie and Hong, Laixin and Pang, Mingyuan and Wang, Zimai and Yang, Min and An, Juan and Pak, Yen Leng and Song, Jibin},
  title = {Bismuth-based nanosystems for precise tumor theranostics: Recent progress, challenges and perspectives},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.140822}
}
Kostenlos starten →